Anemia probe focuses on dialysis treatment
DIALYSIS solution is suspected of being the cause of anemia in 23 patients in a state-owned hospital in east China's Jiangsu Province.
One patient died of complications at Lianyungang City No. 1 People's Hospital after his red blood cell levels dropped earlier this month.
The other 22 affected patients - out of 79 who were receiving dialysis at the hospital - are in a stable condition, said the local health bureau.
An investigation is under way to pinpoint the cause.
The solution is made by dissolving dialysis powder in processed tap water.
Tests have found the water safe, according to a monitoring center under the Ministry of Land and Resources, Xinhua news agency reported yesterday.
Attention has now turned to the powder itself. Samples have been sent to testing centers in the provincial capital Nanjing, Shanghai, Beijing and Tianjin for examination.
The remaining 600 bags in the batch have been sealed.
However, a lack of national standards makes it difficult for the hospital to determine whether ingredients are safe.
The hospital is seeking to conduct further tests, it was reported. Earlier investigations by the hospital and health authorities found no contamination in the treatment.
The Lianyungang hospital suspended dialysis treatment on December 22 and transferred dialysis patients to other hospitals.
A patient, surnamed Zhou, died after suffering a stroke following dialysis at the hospital, the hospital said. A postmortem is required to determine whether Zhou's death is linked to dialysis solution, local officials said.
One patient died of complications at Lianyungang City No. 1 People's Hospital after his red blood cell levels dropped earlier this month.
The other 22 affected patients - out of 79 who were receiving dialysis at the hospital - are in a stable condition, said the local health bureau.
An investigation is under way to pinpoint the cause.
The solution is made by dissolving dialysis powder in processed tap water.
Tests have found the water safe, according to a monitoring center under the Ministry of Land and Resources, Xinhua news agency reported yesterday.
Attention has now turned to the powder itself. Samples have been sent to testing centers in the provincial capital Nanjing, Shanghai, Beijing and Tianjin for examination.
The remaining 600 bags in the batch have been sealed.
However, a lack of national standards makes it difficult for the hospital to determine whether ingredients are safe.
The hospital is seeking to conduct further tests, it was reported. Earlier investigations by the hospital and health authorities found no contamination in the treatment.
The Lianyungang hospital suspended dialysis treatment on December 22 and transferred dialysis patients to other hospitals.
A patient, surnamed Zhou, died after suffering a stroke following dialysis at the hospital, the hospital said. A postmortem is required to determine whether Zhou's death is linked to dialysis solution, local officials said.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.